Abs Biotechnologies Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Abs Biotechnologies General Information

Description

Developer of stem cell-based drug testing and biological analysis systems designed for assessing drug safety in preclinical research. The company's platform includes human stem cell-derived vascular and cardiac cell models, in vitro toxicity screening methods, laboratory-based cell culture processes, and analytical testing workflows used to evaluate compound effects on biological systems, enabling pharmaceutical and biotechnology organizations to identify safety risks in drug development at early research stages with improved biological relevance and experimental consistency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Technopark 1, Haus C
  • Tulln an der Donau, 3430
  • Austria
+43 0678
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Other Healthcare Technology Systems
Corporate Office
  • Technopark 1, Haus C
  • Tulln an der Donau, 3430
  • Austria
+43 0678

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abs Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. University Spin-Out Completed Startup
To view Abs Biotechnologies’s complete valuation and funding history, request access »

Abs Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abs Biotechnologies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
IMAGINE IF! Accelerator/Incubator
Accent Gründerservice Accelerator/Incubator
University of Cambridge University
To view Abs Biotechnologies’s complete investors history, request access »

Abs Biotechnologies FAQs

  • When was Abs Biotechnologies founded?

    Abs Biotechnologies was founded in 2022.

  • Where is Abs Biotechnologies headquartered?

    Abs Biotechnologies is headquartered in Tulln an der Donau, Austria.

  • What is the size of Abs Biotechnologies?

    Abs Biotechnologies has 10 total employees.

  • What industry is Abs Biotechnologies in?

    Abs Biotechnologies’s primary industry is Discovery Tools (Healthcare).

  • Is Abs Biotechnologies a private or public company?

    Abs Biotechnologies is a Private company.

  • What is Abs Biotechnologies’s current revenue?

    The current revenue for Abs Biotechnologies is .

  • Who are Abs Biotechnologies’s investors?

    IMAGINE IF!, Accent Gründerservice, and University of Cambridge have invested in Abs Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process